Literature DB >> 24641219

Possible role of vascular risk factors in Alzheimer's disease and vascular dementia.

Mehrul Hasnain, W Victor R Vieweg1.   

Abstract

The contribution of vascular risk factors to Alzheimer-vascular spectrum dementias is increasingly being recognized. We provide an overview of recent literature on this subject. Overweight and obesity as well as underweight during midlife predict cognitive decline and dementia later in life. Hypertension during midlife is also associated with dementia later in life and the association is stronger for untreated hypertension. Calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin-1 receptor-blockers may be particularly beneficial in diminishing the risk of dementia associated with hypertension. Studies have fairly consistently shown that type 2 diabetes is a risk factor for dementia. Episodes of hypoglycemia add to this risk. Regular physical exercise during any point in the lifespan protects against cognitive decline and dementia. Most benefit is realized with physical exercise during early and midlife. Dyslipidemia also increases the risk of dementia but the findings are less consistent. Findings on the possible benefit of lipid-lowering agents (statins) are conflicting. Earlier studies identified smoking as protective of dementia but recent better designed studies have consistently shown that smoking increases the risk of dementia. The association of vascular risk factors with dementia is more robust for vascular dementia than Alzheimer's disease. Heterogeneity of studies and lack of trials specifically designed to assess cognition as an endpoint make firm conclusions difficult. But considering the expected global burden of dementia and projected attributable risk of vascular risk factors to it, there is sufficient evidence to promote vascular risk factor reduction strategies as dementia prevention interventions.

Entities:  

Mesh:

Year:  2014        PMID: 24641219     DOI: 10.2174/1381612820666140314153440

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  10 in total

1.  Polyadenylation of nascent RNA during the embryogenesis of Ilyanassa obsoleta.

Authors:  J R Collier
Journal:  Exp Cell Res       Date:  1975-10-15       Impact factor: 3.905

2.  Association of Anterior Cingulate Glutathione with Sleep Apnea in Older Adults At-Risk for Dementia.

Authors:  Shantel L Duffy; Jim Lagopoulos; Zoe Terpening; Simon J G Lewis; Ron Grunstein; Loren Mowszowski; Nathan Cross; Daniel F Hermens; Ian B Hickie; Sharon L Naismith
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

3.  PCSK9 inhibitors and neurocognitive adverse events: exploring the FDA directive and a proposal for N-of-1 trials.

Authors:  Kristopher J Swiger; Seth S Martin
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

Review 4.  Drug treatments in Alzheimer's disease.

Authors:  Robert Briggs; Sean P Kennelly; Desmond O'Neill
Journal:  Clin Med (Lond)       Date:  2016-06       Impact factor: 2.659

5.  Psoriasis and Dementia: A Cross-sectional Study of 121,801 Patients.

Authors:  Khalaf Kridin; Dennis Linder; Guy Shalom; Stefano Piaserico; Meir Babaev; Tamar Freud; Doron Comaneshter; Arnon D Cohen
Journal:  Acta Derm Venereol       Date:  2020-08-19       Impact factor: 3.875

6.  Low vision and the risk of dementia: a nationwide population-based cohort study.

Authors:  Ji-Sun Paik; Minji Ha; Youn Hea Jung; Gee-Hyun Kim; Kyung-Do Han; Hyun-Seung Kim; Dong Hui Lim; Kyung-Sun Na
Journal:  Sci Rep       Date:  2020-06-04       Impact factor: 4.379

7.  Effect of acupuncture at 3-points for intelligence on vascular dementia: Protocol for a systematic review and meta-analysis of randomized controlled trials.

Authors:  Weipeng Sun; Minying Li; Tong Lin; Zhizhong Sun; Yizi Xie; Shuliang Ji; Jietao Lin; Lin Wang; Chao Jia; Liang Zheng; Wei Wu; Danghan Xu
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

Review 8.  Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline.

Authors:  Jennifer M Walker; Fiona E Harrison
Journal:  Nutrients       Date:  2015-09-01       Impact factor: 5.717

Review 9.  Effects of Plasma Lipids and Statins on Cognitive Function.

Authors:  Rui Li; Tian-Jun Wang; Pei-Yuan Lyu; Yang Liu; Wei-Hong Chen; Ming-Yue Fan; Jing Xu
Journal:  Chin Med J (Engl)       Date:  2018-02-20       Impact factor: 2.628

10.  Meta-Analysis on the Efficacy and Safety of Hyperbaric Oxygen as Adjunctive Therapy for Vascular Dementia.

Authors:  Qiang You; Lan Li; Su-Qin Xiong; Yu-Fen Yan; Dan Li; Na-Na Yan; Hong-Ping Chen; You-Ping Liu
Journal:  Front Aging Neurosci       Date:  2019-04-17       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.